BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, Dahai, WU, Hao, LIU, Shilan, WANG, Jyhshing, KOZLOWSKI, Joseph, A, GUIADEEN, Deodialsingh, LIU, Jian, BOGA, Sobhana Babu, CAI, Jiaqiang, ALHASSAN, Abdul-Basit, YANG, Chundao, YU, Wensheng, GAO, Xiaolei
Format Patent
LanguageEnglish
French
German
Published 01.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.
AbstractList The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.
Author ALHASSAN, Abdul-Basit
CAI, Jiaqiang
WU, Hao
YANG, Chundao
LIU, Shilan
LIU, Jian
YU, Wensheng
GAO, Xiaolei
WANG, Jyhshing
KOZLOWSKI, Joseph, A
WANG, Dahai
GUIADEEN, Deodialsingh
BOGA, Sobhana Babu
Author_xml – fullname: WANG, Dahai
– fullname: WU, Hao
– fullname: LIU, Shilan
– fullname: WANG, Jyhshing
– fullname: KOZLOWSKI, Joseph, A
– fullname: GUIADEEN, Deodialsingh
– fullname: LIU, Jian
– fullname: BOGA, Sobhana Babu
– fullname: CAI, Jiaqiang
– fullname: ALHASSAN, Abdul-Basit
– fullname: YANG, Chundao
– fullname: YU, Wensheng
– fullname: GAO, Xiaolei
BookMark eNrjYmDJy89L5WTQcHL1i3L09XRxVfAEko5R_gGRQY5Rnn6uCk4h3gqefh6eTp4h_kHBPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2MjEwNTcyMnQmAglAMQbJa8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE LA BTK DE TYPE BENZAMIDE IMIDAZOPYRAZINES
BENZAMIDIMIDAZOPYRAZIN-BTK-HEMMER
ExternalDocumentID EP3240572B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3240572B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:00:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3240572B13
Notes Application Number: EP20150875975
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&CC=EP&NR=3240572B1
ParticipantIDs epo_espacenet_EP3240572B1
PublicationCentury 2000
PublicationDate 20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 20231101
  day: 01
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Merck Sharp & Dohme LLC
RelatedCompanies_xml – name: Merck Sharp & Dohme LLC
Score 3.498272
Snippet The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&locale=&CC=EP&NR=3240572B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU2yNE9KSjTQBVa-promhgbALJVsmaKblAysXSySk0yAWQq02sLPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwMYKMImpuTjZugb4u_g7qzk7A1lqfkG2oHPnTM2NnIAdJVZgK9oclBlcw5xAm1IKkGsUN0EGtgCgYXklQgxMqXnCDJzOsIvXhBk4fKHz3UAmNOsVizBoOLn6RTn6erq4KgDLGxfHKP-AyCDHKE8_VwWnEG8FTz8PTyfPEP-gYFEGBTfXEGcPXaCV8XDvxbsGwB1nLMbAAuz1p0owKBhZWhhZmgF7QylpJuBTyCxTU1JMLdJSTcBXgxlLMkjiNEYKj5w0AxconCDb6WQYWEqKSlNlgfVqSZIcOEQAe5930w
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JT4NAFH5pqrHetGqsKwdDvBArhQIHYliGgC1LEE3thXRgmvRSG4vx7_sYafWit8lM8mbJfPPmm3kLwA2jhkbprC-h8lUl5b6PkCqMUqIFahe9oApCqra2iIb-s_I4USctWGx8YXic0E8eHBERVSDeK35er34esVxuW7m-owusenvwMtMVG3aMlxXcYqJrmySJ3dgRHQdLYpSaddw5VZNtJEo7eMPWajCQF7t2Sln91ijeAewmKGxZHUKLLbvQcTaJ17qwFzb_3VhsoLc-glubRFMrDFwi4HnjWtM4eU2taRARwc5GQhD5gR1kcfp0DIJHMseXsMt8O72cJNvBDU6gjayfnYIgG7psDJENlXOFRyEzWFmq-pwpPDXYoAe9P8Wc_dN2DR0_C8f5OIhG57Bfr9m3a90FtKv3D3aJOraiV3x1vgBFVXrG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BENZAMIDE+IMIDAZOPYRAZINE+BTK+INHIBITORS&rft.inventor=WANG%2C+Dahai&rft.inventor=WU%2C+Hao&rft.inventor=LIU%2C+Shilan&rft.inventor=WANG%2C+Jyhshing&rft.inventor=KOZLOWSKI%2C+Joseph%2C+A&rft.inventor=GUIADEEN%2C+Deodialsingh&rft.inventor=LIU%2C+Jian&rft.inventor=BOGA%2C+Sobhana+Babu&rft.inventor=CAI%2C+Jiaqiang&rft.inventor=ALHASSAN%2C+Abdul-Basit&rft.inventor=YANG%2C+Chundao&rft.inventor=YU%2C+Wensheng&rft.inventor=GAO%2C+Xiaolei&rft.date=2023-11-01&rft.externalDBID=B1&rft.externalDocID=EP3240572B1